AS211349 is a dormant autonomous system number registered under the name MAINCARE-AS, with no active routing or prefixes. The name points to Maincare Solutions SAS, a French healthcare software company, but no operational link is confirmed. The ASN’s only observable surface is its RIPE NCC registry entry. Primary risk is analytical misattribution of operational status. Watchpoints include first BGP announcement, registry record updates, and company acknowledgment.
AS211349 holds a public ASN registration but no operational network role. It does not announce IP prefixes, maintain peering sessions, or participate in global routing. The AS name references Maincare Solutions SAS, yet no publicly verified administrative linkage supports treating the ASN as part of the company's infrastructure.
A dormant ASN that shares the name of a healthcare software provider warrants monitoring because its activation would alter Internet routing maps that feed dependency analysis for healthcare-critical networks. Even while inactive, the naming similarity creates a risk that analysts incorrectly model the ASN as an active network node, leading to flawed connectivity assessments and misplaced risk prioritizations.
A dormant ASN that shares the name of a healthcare software provider warrants monitoring because its activation would alter Internet routing maps that feed dependency analysis for healthcare-critical networks. Even while inactive, the naming similarity creates a risk that analysts incorrectly model the ASN as an active network node, leading to flawed connectivity assessments and misplaced risk prioritizations.
AS211349 holds a public ASN registration but no operational network role. It does not announce IP prefixes, maintain peering sessions, or participate in global routing. The AS name references Maincare Solutions SAS, yet no publicly verified administrative linkage supports treating the ASN as part of the company's infrastructure.
The primary consequence of the current public signals is an analytical hazard: downstream risk models may incorporate AS211349 as an active operator, producing false routing dependencies. If the ASN later announces prefixes, it would affect how infrastructure intelligence platforms map reachability for organizations that depend on Maincare’s healthcare software, potentially shifting risk apportionment incorrectly.
AS211349 is a dormant autonomous system number registered under the name MAINCARE-AS, with no active routing or prefixes. The name points to Maincare Solutions SAS, a French healthcare software company, but no operational link is confirmed. The ASN’s only observable surface is its RIPE NCC registry entry. Primary risk is analytical misattribution of operational status. Watchpoints include first BGP announcement, registry record updates, and company acknowledgment.
The primary consequence of the current public signals is an analytical hazard: downstream risk models may incorporate AS211349 as an active operator, producing false routing dependencies. If the ASN later announces prefixes, it would affect how infrastructure intelligence platforms map reachability for organizations that depend on Maincare’s healthcare software, potentially shifting risk apportionment incorrectly.
| 0.90–1.00 | A | High — direct sources |
| 0.75–0.89 | A/B | Strong |
| 0.55–0.74 | B/C | Medium |
| 0.35–0.54 | C/D | Weak–medium |
| 0.10–0.34 | D | Weak signal |
| 0.00–0.09 | D | Internal monitoring |
多个公开来源
MAINCARE-AS Maincare Solutions SAS
AS211349 是一个在 RIPE NCC 数据库中注册为 MAINCARE-AS 的休眠自治系统号。它没有活跃的路由、未分配任何前缀,也无对等连接。AS 名称暗示与法国医疗软件公司 Maincare Solutions SAS 存在名义上的关联,但没有任何公共注册联系人或公司文件证实这种联系。
该 ASN 存在错误操作假设的分析风险,如果它变得活跃,将为医疗依赖性映射引入可达性变量。 另见: MAINCARE-AS Maincare Solutions SAS.
为何重要
当前公共信号的主要后果是分析性危害:下游风险模型可能将 AS211349 视为活跃运营商,产生虚假的路由依赖性。如果该 ASN 日后宣告前缀,将影响基础设施情报平台为依赖 Maincare 医疗软件的组织映射可达性的方式,可能导致错误地重新分配风险。 另见: VoltzzNode Enterprise SRL.
来源显示
AS211349 是一个在 RIPE NCC 数据库中注册为 MAINCARE-AS 的自治系统号。它目前没有活跃的 BGP 宣告、分配的 IP 前缀或对等关系。尽管名称与法国医疗软件供应商 Maincare Solutions SAS 相似,但这种联系仍未得到任何公共注册联系人或公司文件的确认。该 ASN 仅作为一个休眠的注册条目存在。 另见: Pronect Technology LTD.
如果 AS211349 被激活,它可能引入路由路径,干扰依赖 Maincare 软件的医疗网络的依赖性分析。这可能导致分析师误判连接风险,可能忽视或夸大基础设施依赖性。目前,主要危险在于分析层面:将静默的注册条目视为活跃运营商,扭曲了风险模型。 另见: Alexis Lurot.
RIPEstat、BGP.tools 和 PeeringDB 等公共来源证实,AS211349 没有路由足迹。Maincare Solutions SAS 运营一个网站,描述其数字医疗解决方案,并在法国公司注册处列出,但其公共材料中均未提及此 ASN。RIPE 注册库显示,没有组织对象或行政联系人将两者联系起来。 另见: PG 软件技术有限公司.
AS211349 的唯一控制点是其在 RIPE NCC 注册库中的条目。对 WHOIS/RDAP 记录的任何修改,如添加技术联系人或组织字段,都可能澄清所有权。Maincare 自身的控制表面——其网站和公司备案——目前无法弥合这一差距,因此 ASN 的操作表面仍然不透明。 另见: 罗伯特·纽沃斯.
最有信息价值的信号将是 AS211349 的首次 BGP 宣告、其注册记录中包含联系人或组织对象的更新,或 Maincare Solutions SAS 承认该 ASN 的任何公开声明。出现具名的个人作为行政联系人也将显著改变评估。 另见: 尤金·贡恰连科.
AS211349 的实际控制者未知。在没有文件记录的联系的情况下,无法将 ASN 归属于该公司或排除第三方注册的可能性。名称字符串的推断是这种联系的唯一基础,这对于自信的操作映射是不够的。在路由开始或公司文件出现之前,必须将该 ASN 视为一个潜在的、未分配的资源。
操作表面
AS211349 持有公开的 ASN 注册,但没有操作网络角色。它不宣告 IP 前缀、不维持对等会话、不参与全球路由。AS 名称引用了 Maincare Solutions SAS,但没有任何公开验证的行政联系支持将该 ASN 视为该公司基础设施的一部分。
一个与医疗软件提供商同名的休眠 ASN 值得监控,因为它的激活将改变互联网路由地图,这些地图为关键医疗网络的依赖性分析提供信息。即使在非活跃状态下,名称的相似性也会造成风险,即分析师错误地将 ASN 建模为活跃网络节点,导致错误的连接评估和错误的风险优先级排序。
观察点
AS211349 代表一个潜在的网络标识符,如果被激活,可能会改变法国医疗基础设施的依赖性轮廓。它目前的休眠状态限制了影响,但与医疗软件公司的名义联系造成了一种没有证据支持的操作重要性认知。策略应将 ASN 视为休眠资源,直到路由或注册证据证明并非如此,并避免将命名误读为操作控制。
RIPE NCC 记录的变更——如新的组织对象或联系人——将澄清所有权。AS211349 的首次 BGP 宣告将使其转变为活跃运营商,并需要重新评估医疗网络依赖性。Maincare Solutions SAS 发布任何提及该 ASN 的技术文档也将改变其概况。
没有 WHOIS/RDAP 组织对象或联系人将 ASN 与 Maincare Solutions SAS 联系起来。不存在路由数据、前缀分配、对等记录或操作流量。公司自身的材料未引用该 ASN。为了弥合差距,需要公开的注册更新或直接的公司披露。
来源
- RIPEstat AS 概览 - RIPEstat 公开了 AS211349 的 AS 概览数据,AS 名称为 'MAINCARE-AS'。
- BGP.tools ASN 页面 - BGP.tools 发布了 AS211349 的公共 ASN 页面,显示无活跃路由宣告。
- PeeringDB 网络搜索 - PeeringDB 搜索确认该 ASN 存在,但列出无活跃对等会话。
- Maincare Solutions SAS 网站 - Maincare 公开介绍自己是提供医疗组织数字解决方案/软件的公司。
- 法国公司注册聚合器 (societe.com) - 法国公司注册聚合器提供公共路径,以验证 Maincare Solutions SAS 作为公司实体的法律存在。
运营领域
MAINCARE-AS Maincare Solutions SAS 的公开档案基于可见角色、运营背景和相关报道。
- 公开角色: MAINCARE-AS Maincare Solutions SAS 通过公开角色、服务背景和可复核资料进入 BTW 的观察范围。 证据基础: RIPEstat AS overview — RIPEstat exposes AS overview data for AS211349 with AS name 'MAINCARE-AS'.; BGP.tools ASN page — BGP.tools publishes a public ASN page for AS211349 that shows no active routing announcements.
- 运营面: Digital infrastructure institution 与 France 构成该机构档案的公开语境。 证据基础: RIPEstat AS overview — RIPEstat exposes AS overview data for AS211349 with AS name 'MAINCARE-AS'.; BGP.tools ASN page — BGP.tools publishes a public ASN page for AS211349 that shows no active routing announcements.
时间线
- MAINCARE-AS Maincare Solutions SAS 公开档案更新
公开报道将 MAINCARE-AS Maincare Solutions SAS 记录为需要按角色、运营语境和证据继续观察的主体。
概要
- 名称: MAINCARE-AS Maincare Solutions SAS
- 类型: Digital infrastructure institution
- 所在地: France
- 档案重点: Institution
功能说明
- public operating records
- official service pages
- documented relationships updates
重要性
- The primary consequence of the current public signals is an analytical hazard: downstream risk models may incorporate AS211349 as an active operator, producing false routing dependencies. If the ASN later announces prefixes, it would affect how infrastructure intelligence platforms map reachability for organizations that depend on Maincare’s healthcare software, potentially shifting risk apportionment incorrectly.
- 运营关键性: Medium
- 时间范围: Next quarter
关注事项
- official company sources
- public registries
- operator-published records
跟踪经验证的来源更新、角色变化和当前公开证据。
The primary consequence of the current public signals is an analytical hazard: downstream risk models may incorporate AS211349 as an active operator, producing false routing dependencies. If the ASN later announces prefixes, it would affect how infrastructure intelligence platforms map reachability for organizations that depend on Maincare’s healthcare software, potentially shifting risk apportionment incorrectly.
长期相关性取决于经验证的运营、政策和关系变化。
会员简报
深度档案背景
登录后可解锁完整档案简报和来源说明。
公开视角
MAINCARE-AS Maincare Solutions SAS 的公开解读限于可见角色、运营语境和有证据支撑的关系。
观察点
- 新的公开角色、合作、产品、政策或市场披露。
- 涉及具名组织或人物的已验证关系变化。
限制说明
- 私人或未经验证的说法不进入公开视图。
常见问题
为什么收录 MAINCARE-AS Maincare Solutions SAS?
MAINCARE-AS Maincare Solutions SAS 有公开证据显示其与数字基础设施、治理或市场报道相关。
这个档案的公开部分是什么?
公开层覆盖可见角色、运营语境、关联主体和有证据支撑的观察点。
读者接下来应关注什么?
读者应关注有来源支持的角色变化、新合作、监管暴露、运营扩张或会改变公开评估的证据。






